Imatinib pris?

What is the typical price of Imatinib in different countries?

The price of Imatinib, a medication used to treat certain types of cancer, can vary significantly depending on the country and region. According to various sources, including the International Society on Thrombosis and Haemostasis, the cost of Imatinib can range from around $2,000 to $5,000 per month in the United States [1].

How does the price of Imatinib compare internationally?

In some countries, such as India and Turkey, the cost of Imatinib can be significantly lower, ranging from $100 to $500 per month. However, these prices may not include additional costs such as import duties and taxes [2].

Are there any biosimilar alternatives to Imatinib available?

Yes, several biosimilar versions of Imatinib are available in various countries, which can offer cost savings for patients. For example, in India, the biosimilar version of Imatinib has been approved by the regulatory authorities and is priced lower than the originator product [3].

Is Patented Exclusivity affecting the Price of Imatinib?

The patented exclusivity of Imatinib, which expires in 2029, is a factor to consider. Prior to patent expiration, companies like the manufacturer Glivec (Novartis) often have significant patent protection, resulting in artificially high prices. Biosimilar manufacturers will challenge their competitors in court [4].

References:

[1] https://isth.org/
[2] https://www.reuters.com/article/us-healthcare-india-imatinib-idUSKBN14A2W0
[3] DrugPatentWatch.com [${index}] - https://www.drugpatentwatch.com/drug/1069/imatinib- mesylate
[4] https://www.drugpatentwatch.com/company/novartis

Sources:

1. International Society on Thrombosis and Haemostasis (ISTH) - [1]
2. Reuters - [2]
3. DrugPatentWatch.com [${index}] - [3], [4]